You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國同輻(01763.HK):原子高科披露業績快報,年度淨利升20.89%至2.68億元
格隆匯 03-30 17:25

格隆匯3月30日丨中國同輻(01763.HK)發佈公吿,原子高科披露2021年年度業績快報,2021年度,原子高科實現營業總收入人民幣13.25億元,同比上升11.51%,實現歸屬於掛牌原子高科股東的淨利潤2.68億元,同比上升20.89%。收入增幅主要原因為,原子高科放射性藥物收入增長、新收購企業核醫學整體服務業務營收增長。淨利潤增幅主要原因為,原子高科整體營業收入增長及參股企業的投資收益增長。

2021年,原子高科放射性藥物銷售呈現上升趨勢,受疫情影響基本恢復。近幾年,國內核醫學整體發展迅速,尤其是正電子藥物診斷方向,配套儀器設備數量逐年增加,診斷治療效果得到臨牀科室和病人的認可。同時,隨着原子高科新建醫藥中心的不斷投入運營,原子高科產品覆蓋面更廣,客户數量不斷增加;此外,參股企業營業收入及淨利潤上升,使得原子高科投資收益增長。以上為原子高科業績增長的主要原因。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account